QYNAPSE
Healthcare Software · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
130 Rue De Lourmel, Paris, Ile-de-France...Website
www.qynapse.comRevenue
<$5 MillionIndustry
About QYNAPSE
QYNAPSE Org Chart
Is QYNAPSE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if QYNAPSE has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at QYNAPSE
Funding: Get notified immidiatlly once QYNAPSE has new funding data
Earning: See what the market has to say on QYNAPSE recently announced quarterly report
QYNAPSE, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when QYNAPSE launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if QYNAPSE is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if QYNAPSE had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined QYNAPSE as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
QYNAPSE is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
QYNAPSE is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about QYNAPSE.
QYNAPSE financials insights
Gather financial insights about QYNAPSE, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$3M
QYNAPSE Tech Stack
A closer look at the technologies used by QYNAPSE
Most Recent Scoops
QYNAPSE News & Media
University of Miami using Qynapse's AI technology to research effects of Covid-19 on neuroimaging markers of cognitive impairment
BOSTON, Sept. 7, 2022 /PRNewswire/ -- Qynapse Inc., a medical technology company with a commercialized Artificial Intelligence (AI) powered neuroimaging analysis platform for central nervous system (CNS) disorders, is pleased to announce a collaborative project with the University of...Calyx and Qynapse Partnering to Enable AI-enhanced Medical Imaging Services for CNS Clinical Trials
Partnership delivers advanced approaches for bringing neurodegenerative disease treatments to market NOTTINGHAM, England and MORRISVILLE, N.C. and BOSTON, July 25, 2022 /PRNewswire/ -- Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data...Qynapse to present symposium oral and poster presentations at AD/PD™ 2022 International Conference
BOSTON, March 3, 2022 /PRNewswire/ -- Qynapse SAS, a medical technology company commercializing an FDA approved/CE cleared AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to announce that a symposium oral presentation and a poster...Qynapse to present new evidence on the value of QyScore® for the diagnosis and monitoring of multiple sclerosis at ACTRIMS Forum 2022
BOSTON, Feb. 14, 2022 /PRNewswire/ -- Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to present two posters at the annual Americas Committee for Treatment and Research in...
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding QYNAPSE
Qynapse is a medical technology company based in Paris, France. The company offers quantitative imaging and AI to optimize diagnosis, prognosis, and longitudinal monitoring of patients for Alzheimer’s and other neurological diseases.... Read More